Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2020 1
2021 2
2022 6
2023 1
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

11 results

Results by year

Filters applied: . Clear all
Page 1
Adipokines and Inflammation: Focus on Cardiovascular Diseases.
Feijóo-Bandín S, Aragón-Herrera A, Moraña-Fernández S, Anido-Varela L, Tarazón E, Roselló-Lletí E, Portolés M, Moscoso I, Gualillo O, González-Juanatey JR, Lago F. Feijóo-Bandín S, et al. Among authors: anido varela l. Int J Mol Sci. 2020 Oct 18;21(20):7711. doi: 10.3390/ijms21207711. Int J Mol Sci. 2020. PMID: 33081064 Free PMC article. Review.
The lipidomic and inflammatory profiles of visceral and subcutaneous adipose tissues are distinctly regulated by the SGLT2 inhibitor empagliflozin in Zucker diabetic fatty rats.
Aragón-Herrera A, Moraña-Fernández S, Otero-Santiago M, Anido-Varela L, Campos-Toimil M, García-Seara J, Román A, Seijas J, García-Caballero L, Rodríguez J, Tarazón E, Roselló-Lletí E, Portolés M, Lage R, Gualillo O, González-Juanatey JR, Feijóo-Bandín S, Lago F. Aragón-Herrera A, et al. Among authors: anido varela l. Biomed Pharmacother. 2023 May;161:114535. doi: 10.1016/j.biopha.2023.114535. Epub 2023 Mar 15. Biomed Pharmacother. 2023. PMID: 36931025 Free article.
Relaxin-2 as a Potential Biomarker in Cardiovascular Diseases.
Aragón-Herrera A, Feijóo-Bandín S, Anido-Varela L, Moraña-Fernández S, Roselló-Lletí E, Portolés M, Tarazón E, Gualillo O, González-Juanatey JR, Lago F. Aragón-Herrera A, et al. Among authors: anido varela l. J Pers Med. 2022 Jun 21;12(7):1021. doi: 10.3390/jpm12071021. J Pers Med. 2022. PMID: 35887517 Free PMC article. Review.
Relaxin-2 plasma levels in atrial fibrillation are linked to inflammation and oxidative stress markers.
Aragón-Herrera A, Couselo-Seijas M, Feijóo-Bandín S, Anido-Varela L, Moraña-Fernández S, Tarazón E, Roselló-Lletí E, Portolés M, Martínez-Sande JL, García-Seara J, Álvarez E, González-Juanatey JR, Rodríguez-Mañero M, Eiras S, Lago F. Aragón-Herrera A, et al. Among authors: anido varela l. Sci Rep. 2022 Dec 24;12(1):22287. doi: 10.1038/s41598-022-26836-1. Sci Rep. 2022. PMID: 36566255 Free PMC article.
Role of Sodium-Glucose Co-Transporter 2 Inhibitors in the Regulation of Inflammatory Processes in Animal Models.
Feijóo-Bandín S, Aragón-Herrera A, Otero-Santiago M, Anido-Varela L, Moraña-Fernández S, Tarazón E, Roselló-Lletí E, Portolés M, Gualillo O, González-Juanatey JR, Lago F. Feijóo-Bandín S, et al. Among authors: anido varela l. Int J Mol Sci. 2022 May 18;23(10):5634. doi: 10.3390/ijms23105634. Int J Mol Sci. 2022. PMID: 35628443 Free PMC article. Review.
Cardiac Sodium/Hydrogen Exchanger (NHE11) as a Novel Potential Target for SGLT2i in Heart Failure: A Preliminary Study.
Pérez-Carrillo L, Aragón-Herrera A, Giménez-Escamilla I, Delgado-Arija M, García-Manzanares M, Anido-Varela L, Lago F, Martínez-Dolz L, Portolés M, Tarazón E, Roselló-Lletí E. Pérez-Carrillo L, et al. Among authors: anido varela l. Pharmaceutics. 2022 Sep 21;14(10):1996. doi: 10.3390/pharmaceutics14101996. Pharmaceutics. 2022. PMID: 36297433 Free PMC article.
Relaxin has beneficial effects on liver lipidome and metabolic enzymes.
Aragón-Herrera A, Feijóo-Bandín S, Moraña-Fernández S, Anido-Varela L, Roselló-Lletí E, Portolés M, Tarazón E, Lage R, Moscoso I, Barral L, Bani D, Bigazzi M, Gualillo O, González-Juanatey JR, Lago F. Aragón-Herrera A, et al. Among authors: anido varela l. FASEB J. 2021 Jul;35(7):e21737. doi: 10.1096/fj.202002620RR. FASEB J. 2021. PMID: 34143495
The Treatment With the SGLT2 Inhibitor Empagliflozin Modifies the Hepatic Metabolome of Male Zucker Diabetic Fatty Rats Towards a Protective Profile.
Aragón-Herrera A, Otero-Santiago M, Anido-Varela L, Moraña-Fernández S, Campos-Toimil M, García-Caballero T, Barral L, Tarazón E, Roselló-Lletí E, Portolés M, Gualillo O, Moscoso I, Lage R, González-Juanatey JR, Feijóo-Bandín S, Lago F. Aragón-Herrera A, et al. Among authors: anido varela l. Front Pharmacol. 2022 Feb 2;13:827033. doi: 10.3389/fphar.2022.827033. eCollection 2022. Front Pharmacol. 2022. PMID: 35185578 Free PMC article.
11 results